The invention provides porous carbon particles for use in the treatment or prevention of liver disease or complications associated with liver dysfunction, wherein said porous carbon particles comprise micropores of diameter 2 nm or less and mesopores/small macropores of diameter 30 nm to 500 nm, but substantially no mesopores of diameter greater than 2 nm and less than 30nm, and substantially no large macropores of diameter greater than 500 nm.
